The stock gave multibagger returns of 160 per cent in just 1 year and over 300 per cent in 3 years.

This stock has been a phenomenal performer, with returns of over 1,100 per cent in 3 years and over 9,000 per cent in 10 years.

The stock is up by 50 per cent from its 52-week low. 

The stock gave multibagger returns of 105 per cent in 1 year, 450 per cent in 2 years and a whopping 3,000 per cent in 3 years.

The stock gave multibagger returns of 250 per cent in just 1 year, 1,400 per cent returns in 2 years and a whopping 2,800 per cent returns in 3 years.

The stock gave multibagger returns of 340 per cent in just 1 year and over 760 per cent in 3 years.

After rising nearly 35 per cent over the period of 1 year, shares of Vinny Overseas Ltd are undergoing a correction and have hit the lower circuit for the second straight day.

The stock gave multibagger returns of 635 per cent from its 52-week low of Rs 140 per share.

The stock gave multibagger returns of 266 per cent in just 1 year whereas BSE Sensex Index is up by 15.38 per cent.

The shares of the company saw a spurt in volume by more than 2.54 times on BSE and hit back-to-back upper circuits in the recent trading session.

The stock is an SME stock having a lot size of 3,460 shares and currently trading at 0.62 times its book value.

Earlier, the company signed an MoU with Onest Limited for manufacturing and supplying a wide range of products falling into the ayurvedic, cosmetic and disinfectant category.

The shares of the company have an ROE of 40.6 per cent and a ROCE of 27.3 per cent.

The shares of the company have an ROE of 24 per cent and a ROCE of 20 per cent with a 3-year CAGR of 212 per cent respectively.

The stock gave multibagger returns of 671.42 per cent from its 52-week low of Rs 140 per share.

The company made its mark in the international solar market with the announcement of its two turnkey EPC projects in Dubai. The projects worth Rs 101.6 crore will help the company expand its presence in the Middle East.

The net sales increased by 6 per cent to Rs 15.65 crore and the net profit increased by 137 per cent to Rs 1.09 crore in H2FY23 compared to H2FY22. The net sales increased by 28 per cent to Rs 31.19 crore and the net profit increased by 1040 per cent to Rs 1.14 crore in FY23 compared to FY22.

The company has a high level of promoter ownership, with the promoters holding 75 per cent of the shares. The public owns the remaining 25 per cent of the shares.

Earlier, the company announced its stellar quarterly results wherein net sales increased by 44.58 per cent to Rs 187.68 crore and net profit increased by 60.26 per cent to Rs 2.90 crore in Q1FY24 compared to Q1FY23.

The company’s maximum stake is owned by The President of India (55.99 per cent) as of March 2023. The company reported excellent numbers in its quarterly results and annual results.

The company has a high level of promoter ownership, with the promoters holding 75 per cent of the shares. The public owns the remaining 25 per cent of the shares.

According to quarterly results and annual results, the company reported positive numbers. In Q1FY24, the company reported net sales of Rs 76.20 crore and a net profit of Rs 2.49 crore. In FY23, the net sales increased by 23 per cent to Rs 315 crore and net profit increased by 10 per cent to Rs 11 crore compared to FY22.

SEML has a market cap of Rs 107.50 crore. The net sales increased by 77.34 per cent to Rs 60.81 crore and net profit increased by 280.92 per cent to Rs 6.59 crore in H2FY23 over H2FY22.

The company has a high level of promoter ownership, with the promoters holding 75 per cent of the shares. The public owns the remaining 25 per cent of the shares.

The company has a market cap of Rs 348 crore. According to the annual results, the net sales increased by 15.15 per cent to Rs 114 crore and net profit increased by 42.86 per cent to Rs 10 crore in FY23 over FY22.

According to the quarterly results, the net sales increased by 43.14 per cent to Rs 138.16 crore, operating profit increased by 10.24 per cent to Rs 9.8 crore and net profit increased by 14.58 per cent to Rs 4.4 crore in Q1FY24 compared to Q1FY23.

The promoters of the company have increased their stake by 12.6 per cent over the last quarter. The company has a market cap of over Rs 3,500 crore. The stock has an ROE of 30.1 per cent and a ROCE of 34.6 per cent.

The company reported positive numbers in its half-yearly and annual results. Net sales increased by 66.22 per cent to Rs 210.77 crore and net profit increased by 32.61 per cent to Rs 11.67 crore in H2FY23 over H2FY22. Net sales increased by a whopping 144.78 per cent to Rs 392.65 crore and net profit increased by a strong 122.93 per cent to Rs 24.79 crore in FY23 over FY22.

Furthermore, according to the quarterly results, the net sales increased by 17.54 per cent to Rs 67 crore and the net profit skyrocketed by 167 per cent to Rs 10 crore in Q1FY24 compared to Q1FY23. 

The company has a market cap of Rs 551.29 crore. In H2FY23, the net sales increased by 179 per cent to Rs 67 crore compared to H2FY22. The company reported a net profit of Rs 6 crore in H2FY23.

The operating profit skyrocketed by 792.50 per cent to Rs 0.36 crore and the net profit skyrocketed by 1,034.48 per cent to Rs 0.33 crore in Q1FY24 compared to Q1FY23.

The company has a market cap of Rs 1,75,000 crore and a robust order book worth Rs 48,700 crore as of June 30, 2023. The company has been maintaining a healthy dividend payout of 60.0 per cent and the stock is providing a good dividend yield of 4.39 per cent.

In H2FY23, the net sales increased by 8 per cent to Rs 17.76 crore and net profit increased by 15 per cent to Rs 1.75 crore compared to H2FY22. In FY23, the net sales increased by 39 per cent to Rs 38.89 crore and net profit increased by 45 per cent to Rs 4.32 crore compared to FY22.

The company has a market cap of over Rs 9,500 crore and has delivered good profit growth of 39.5 per cent CAGR over the last 5 years. The company reported positive numbers in its quarterly results (Q1FY24) and annual results (FY23).

According to the financials, the company reported amazing numbers in its half-yearly results (H2FY23) and annual results (FY23). The net sales increased by 14.99 per cent to Rs 3.61 crore and the net profit increased by 11.36 per cent to Rs 1.18 crore in FY23 compared to FY22.

Earlier, the company announced its stellar quarterly results wherein net sales increased by 44.58 per cent to Rs 187.68 crore and net profit increased by 60.26 per cent to Rs 2.90 crore in Q1FY24 compared to Q1FY23.

The company reported positive numbers in its half-yearly results and annual results. The net sales increased by 66.22 per cent to Rs 210.77 crore and net profit increased by 32.61 per cent to Rs 11.67 crore in H2FY23 over H2FY22.

Additionally, the company reported excellent numbers in its quarterly results (Q1FY24) and annual results (FY23). The net sales increased by 152.30 per cent to Rs 165 crore and the net profit increased by 100 per cent to Rs 12 crore in Q1FY24 over Q1FY23.

The company has a market cap of Rs 175.85 crore and has delivered good profit growth of 86.8 per cent CAGR over the last 5 years. The company reported positive numbers in its quarterly results and annual results.

According to the quarterly results, the net sales increased by 26 per cent to Rs 3.58 crore and the net profit skyrocketed 277 per cent to Rs 0.34 crore in Q1FY24 compared to Q1FY23. According to the annual results, the net sales increased by 38 per cent to Rs 13.27 crore and the net profit skyrocketed by 2,357 per cent to Rs 1.58 crore in FY23 compared to FY22.

The company reported positive numbers in its quarterly results and annual results. In FY23, net sales increased by 101 per cent to Rs 982 crore and net profit skyrocketed by 117.50 per cent to Rs 124 crore compared to FY22.

According to the quarterly results, the net sales increased by 43.14 per cent to Rs 138.16 crore, operating profit increased by 10.24 per cent to Rs 9.8 crore and net profit increased by 14.58 per cent to Rs 4.4 crore in Q1FY24 compared to Q1FY23.

According to the financials, the company has a market cap of Rs 521.20 crore and has delivered good profit growth of 37.9 per cent CAGR over the last 5 years. Additionally, the company has reported amazing numbers in its quarterly results and annual results.

Madhya Bharat Agro Products Ltd, part of Ostwal Group, is engaged in the business of manufacturing fertiliser and chemical products. The company has a market cap of over Rs 2,700 crore with a 5-year stock price CAGR of 93 per cent. The company reported positive numbers in its quarterly results and annual results.

According to the half-yearly results, the net sales increased by 51.25 per cent to Rs 62.01 crore and net profit increased by 51 per cent to Rs 2.88 crore in H2FY23 compared to H2FY22. In FY23, the net sales increased by 14.50 per cent to Rs 95.13 crore and net profit increased by 18.73 per cent to Rs 4.50 crore compared to FY22.

Earlier, the company announced its stellar quarterly results wherein net sales increased by 44.58 per cent to Rs 187.68 crore and net profit increased by 60.26 per cent to Rs 2.90 crore in Q1FY24 compared to Q1FY23.

According to the half-yearly results, the net sales increased by 154 per cent to Rs 46.54 crore and net profit increased by 63 per cent to Rs 1.53 crore in H2FY23 compared to H2FY22. In FY23, the net sales increased by 128 per cent to Rs 70.23 crore and net profit increased by 475 per cent to Rs 3.91 crore compared to FY22.

Additionally, the company reported excellent numbers in its half-yearly and annual results. The net sales increased by 27.50 per cent to Rs 9.85 crore and net profit skyrocketed 325 per cent to Rs 0.34 crore in H2FY23 compared to H2FY22.

SEML has a market cap of Rs 109.30 crore. The net sales increased by 77.34 per cent to Rs 60.81 crore and net profit increased by 280.92 per cent to Rs 6.59 crore in H2FY23 over H2FY22. The net sales increased by 50.66 per cent to Rs 96.83 crore and net profit increased by 63.60 per cent to Rs 8 crore in FY23 over FY22.

According to the quarterly results, the net sales increased by 189 per cent to Rs 8.46 crore, and the net profit increased by 113 per cent to Rs 0.49 crore in Q4FY23 compared to Q3FY23. In FY23, the net sales increased by 46.65 per cent to Rs 11.38 crore, and the net profit increased by 84.61 per cent to Rs 0.72 crore compared to FY22.

The company has a market cap of over Rs 2,700 crore with a 5-year stock price CAGR of 95 per cent. The company reported positive numbers in its quarterly results and annual results.

The company reported net sales of Rs 374.02 crore in Q1FY24 compared to net sales of Rs 375.17 crore in Q1FY23. The operating profit increased by 16 per cent to Rs 59 crore and the net profit increased by 23 per cent to Rs 33 crore in Q1FY24 compared to Q1FY23. 

Earlier, the company signed a contract to supply "WHIDENT" range of toothpaste to Casablanca, Morocco (North West Africa) as a part of its expansion plan. The company has already been successfully manufacturing and exporting various types of toothpaste to East African countries.

The net sales increased by 6 per cent to Rs 15.65 crore and the net profit increased by 137 per cent to Rs 1.09 crore in Q4FY23 compared to Q4FY22. The net sales increased by 28 per cent to Rs 31.19 crore and the net profit increased by 1040 per cent to Rs 1.14 crore in FY23 compared to FY22.

The company has a market cap of over Rs 1,300 crore and has delivered good profit growth of 49.8 per cent CAGR over the last 5 years.  Additionally, the company reported excellent numbers in its quarterly results (Q1FY24) and annual results (FY23).

The stock gave is up by 85 per cent in 3 years and gave multibagger returns of over 230 per cent in 1 decade.

Additionally, the company announced stellar quarterly results. The total revenue stood at Rs 16.14 crore, up 53.3 per cent, EBITDA stood at Rs 0.80 crore, up 166.7 per cent and Profit After Tax (PAT) stood at Rs 0.51 crore, up 61.3 per cent in Q1FY24 compared to Q1FY23.

The Board of Directors of the company have approved a sub-division/ split of the company’s 1 equity share of the company having a face value of Rs 10 each into 10 equity shares of the company having a face value of Rs 1 each and bonus shares in the ratio of 2:1.

The company has a market cap of over Rs 1,300 crore with a 5-year stock price CAGR of 92 per cent. The shares of the company saw a spurt in volume by more than 1.39 times on BSE.

The company has a market cap of Rs 39 crore and it's almost debt free. The shares of the company saw a spurt in volume by more than 2.19 times on BSE.

The company does manufacturing and trading of various types of Specialty Chemicals viz, water-based adhesives and solvent-based adhesives. The company has a market cap of Rs 58 crore with a 5-year CAGR of 39 per cent. The company reported excellent numbers in its quarterly results and annual results.

The shares of the company have an ROE of 71 per cent and a ROCE of 103 per cent. The stock has delivered mind-boggling returns for investors, generating multibagger returns of 1,710 per cent in just 6 months, 3,270 per cent in 1 year, 16,600 per cent in 3 years, and over 33,000 per cent in 1 decade.

According to the annual results, the net sales increased by 75.89 per cent to Rs 1,091 crore and net profit increased by 38.73 per cent to Rs 39.40 crore in FY23 over FY22. The shares of the company have a PE of 16x, an ROE of 16 per cent and a ROCE of 18 per cent.

The company reported net sales of Rs 30.17 crore in Q1FY24 compared to a net sales of Rs 33.46 per cent in Q1FY23 while the net profit increased by 2.24 per cent to Rs 5.95 crore in Q1FY24 compared to Q1FY23. In FY23, net sales increased by 37.37 per cent to Rs 137.39 crore and net profit increased by 41.40 per cent to Rs 25.22 crore compared to FY22.

In the fourth quarter of fiscal year 2023 (Q4FY23), the company's net sales were 129.81 crores, which is lower than the net sales of 202.35 crores in Q4FY22. However, the net profit increased by 81 per cent to 1.81 crores in Q4FY23 compared to 1.01 crores in Q4FY22.

Penny stock Taparia Tools shines amid green market, locked in the upper circuit after securing order; robust profit growth, healthy dividend payout, and impressive financials make it a stock to watch!

According to the quarterly results, the company reported net sales of Rs 14.08 crore. The operating profit skyrocketed by 792.50 per cent to Rs 0.36 crore and net profit skyrocketed by 1,034.48 per cent to Rs 0.33 crore in Q1FY24 compared to Q1FY23.

This company is a large-cap having a market cap of over Rs 70,000 crore. According to the quarterly and annual financial results, the company reported positive numbers. The company has been maintaining a healthy dividend payout of 36.70 per cent.

The company reported net sales of Rs 129.81 crore in Q4FY23 compared to net sales of Rs 202.35 crore in Q4FY22 while the net profit increased by 81 per cent to Rs 1.81 crore in Q4FY23 over Q4FY22. The net sales increased by 14 per cent to Rs 689 crore and net profit skyrocketed by 167 per cent to Rs 8 crore in FY23 over FY22.

As of the date, the company has a paid-up equity capital of Rs. 10.32 crore, consisting of 10.32 million shares of Rs 10 each. After the bonus issue, the paid-up equity capital will increase to Rs 18.58 crore, consisting of 18.58 million shares of Rs 10 each.

Additionally, the company approved raising funds up to Rs 12,000 crore from the domestic market through the issue of secured/unsecured, non-convertible, non-cumulative/cumulative, redeemable, taxable/tax-free debentures/bonds under private placement during the financial year 2024-2025 in one or more tranches/offers subject to the approval of shareholders of the company.

The company has a market cap of over Rs 3,000 crore. The stock has an ROE of 42.93 per cent and a ROCE of 37.08 per cent. The promoters of the company have increased their stake by 12.6 per cent over the last quarter.

Anmol India Ltd. is delighted to announce its outstanding performance in the first quarter of the fiscal year 2024, as evidenced by the remarkable financial updates. We are thrilled to report a robust growth trajectory, with significant improvements across key financial metrics.

The pre-bonus issue paid-up equity capital as of the date of this letter is Rs 10.32 crore consisting of 1,03,20,000 equity shares of Rs 10 each. The post-bonus paid-up equity share capital shall be Rs 18.58 crore consisting of 1,85,76,000 equity shares of Rs 10 each. From Rs 10.67 per share to Rs 642.70 per share, the stock gave astounding returns of 5,900 per cent in just 5 years.

The company recommended a final dividend of Rs 4.75 per share (i.e., 47.50 per cent on the paid-up equity share capital) for the financial year 2022-23. The company fixed the record date for the final dividend as Tuesday, August 08, 2023.

According to the financials, the company has a market cap of 21.17 crore. The net sales increased by 74.50 per cent to Rs 13.76 crore and net profit increased by 53.64 per cent to Rs 0.34 crore in H2FY23 over H2FY22. The net sales increased by 70.26 per cent to Rs 22.55 crore and net profit increased by 34.06 per cent to Rs 0.67 crore in FY23 over FY22.

According to the annual results, the net sales increased by per cent to Rs 1,583 crore and net profit increased by per cent to Rs 130 crore in FY23 compared to FY22. The EPS for FY23 stood at Rs 60.66. The scrip has a PE of 14.70x, a ROE of 20 per cent and a ROCE of 21.60 per cent.

Recently, The Board of Directors of the company have recommended and approved the bonus Issue of equity shares in the proportion of 1 equity share of Rs 1 each for every 2 Equity Shares of Rs 1 each held by shareholders of the company as on the record date. The share ex-record date was Wednesday, June 19, 2023.  

According to the annual results, the net sales increased by 11.36 per cent to Rs 16.72 crore and net profit increased by 201.73 per cent to Rs 0.70 crore in FY23 over FY22. Additionally, the company announced bonus shares in the ratio 1:2 to its shareholders as of the record date. The ex-bonus date was Wednesday, May 03, 2023.

The net sales increased by 103.78 per cent and net profit increased by 77 per cent in Q4FY23 over Q4FY22. The net sales increased by 42.21 per cent and the net profit skyrocketed by 127.34 per cent in FY23 over FY22. The stock has a PE of 10.04x and a ROE of 47.81 per cent.

According to the financials, the company have a market cap of over Rs 582.51 crore with a 3-year CAGR of 262 per cent. The company reported amazing numbers in its quarterly results and annual results. From Rs 10.67 per share to Rs 564.45 per share, the stock gave astounding returns of 5,190 per cent in just 5 years.

In terms of shareholding pattern, the maximum stake is owned by promoters of the company (71.77 per cent) and the rest is owned by the general public (28.23 per cent).

The company has a market cap of Rs 205 crore. According to the annual results, the net sales increased by 15.15 per cent to Rs 114 crore and net profit increased by 42.86 per cent to Rs 10 crore in FY23 over FY22.

According to the annual results, the net sales increased by per cent to Rs 1,583 crore and net profit increased by per cent to Rs 130 crore in FY23 compared to FY22. The EPS for FY23 stood at Rs 60.66.

The company reported net sales of Rs 129.81 crore in Q4FY23 compared to net sales of Rs 202.35 crore in Q4FY22 while the net profit increased by 81 per cent to Rs 1.81 crore in Q4FY23 over Q4FY22. The net sales increased by 14 per cent to Rs 689 crore and net profit skyrocketed by 167 per cent to Rs 8 crore in FY23 over FY22.

On Tuesday, the benchmark indices traded positively, with the NSE Nifty-50 Index rising by 0.19 per cent to a level of 19,745.25. Additionally, the Nifty-50 Index achieved a new 52-week high at 19,819.45.

As of March 2023, the shareholding pattern of the company indicates that the majority stake of 62.08 per cent is held by the company's promoters, while the remaining ownership is divided among FIIs (0.25 per cent) and the general public (37.68 per cent).

In terms of shareholding pattern, the maximum stake is owned by promoters of the company (71.77 per cent) and the rest is owned by the general public (28.23 per cent). The company reported positive numbers in its quarterly results and annual results.

Earum Pharmaceuticals has a market cap of Rs 36.82 crore. The company reported positive numbers in its both quarterly results and annual results. The stock has a PE of 18.60x whereas the industry PE is 30x.

According to the financials, the company reported excellent numbers in its quarterly results and annual results. The net sales increased by 173.84 per cent to Rs 178 crore and the net profit increased by 26.92 per cent to Rs 33 crore in Q4FY23 over Q4FY22. In FY23, net sales increased by 103.11 per cent to Rs 457 crore and net profit increased by 38.77 per cent to Rs 68 over FY22. The stock has a ROE of 29 per cent and a ROCE of 34.80 per cent.

Additionally, the company reported excellent numbers in its half-yearly and annual results. The net sales increased by 27.50 per cent to Rs 9.85 crore and net profit skyrocketed 325 per cent to Rs 0.34 crore in H2FY23 compared to H2FY22.

The company has bagged an order worth Rs 35 crore for manufacturing A.P. (Active pharmaceuticals Ingredient) purification and sterilization Plant with Lyophilizers in small batch API. The company will create an advanced quality control system and R & D facility in new I.P. creation in the field of API & Intermediaries.

The company reported positive numbers in its quarterly results (Q4FY23) and annual results (FY23). The net sales increased by 75.89 per cent to Rs 1,091 crore and net profit increased by 38.73 per cent to Rs 39.40 crore in FY23 over FY22.

As of March 2023, the shareholding pattern of the company indicates that the majority stake of 62.08 per cent is held by the company's promoters, while the remaining ownership is divided among FIIs (0.25 per cent) and the general public (37.68 per cent).

The company reported excellent numbers in its quarterly results and annual results. The net sales increased by 27.50 per cent to Rs 9.85 crore and net profit skyrocketed 325 per cent to Rs 0.34 crore in H2FY23 compared to H2FY22.

The company entered into an agreement for the purchase of land with Indus Project Ltd and paid approx. Rs 10 crore under the memorandum of agreement. Furthermore, the company has introduced a new plant at our existing Panipat facility dedicated to the production of Thermo Plastic Elastomer (TPE). The estimated investment for the project is Rs 2.50 crore.

On Thursday, the benchmark indices traded positively, with the BSE Sensex Index rising by 0.30 per cent to reach 65,640.66. Additionally, the Sensex Index achieved a new 52-week high at 65,677.96.

Earum Pharmaceuticals Limited produces and distributes pharmaceutical products. The company offers tablets, capsules, ointments, creams, gels, powders, and syrup. Earum Pharmaceuticals markets its products globally.